Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume 158, Issue 1, Pages 15-21Publisher
WILEY
DOI: 10.1111/j.1365-2133.2007.08316.x
Keywords
genetics; melanoma; therapy
Categories
Ask authors/readers for more resources
Melanoma therapy is moving away from combinatorial approaches and towards newer targeted strategies. With the identification of mutations in various RAS pathway genes, there are now tremendous opportunities to bring inhibitors of RAS signalling to the clinical arena.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
